Menu
Back to User profile » Dr Haitao Zhao
Papers published by Dr Haitao Zhao:
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
Ouyang J, Wang Z, Yuan K, Yang Y, Zhou Y, Li Q, Yang N, Zhao H, Zhao H, Zhou J
Journal of Hepatocellular Carcinoma 2023, 10:1465-1477
Published Date: 6 September 2023
Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents
Wang X, Yang X, Wang J, Dong C, Ding J, Wu M, Wang Y, Ding H, Zhang H, Sang X, Zhao H, Huo L
Journal of Hepatocellular Carcinoma 2023, 10:587-598
Published Date: 8 April 2023
Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study
Chen B, Lei J, Zhao H, Dong J, Zeng Z, Li Y, Yu L, Zhou L, Jia A, Lu Y, Cheng J
Journal of Hepatocellular Carcinoma 2022, 9:1171-1185
Published Date: 8 November 2022
Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience
Sun L, Wang D, Zhang M, Jin Y, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y
Cancer Management and Research 2020, 12:12137-12150
Published Date: 25 November 2020
Unleashing The Potential Of Multiple-Targeted Therapies In Hepatobiliary Cancers: Two Cases, Cocktail Therapy With Nine Molecular Targeted Agents And Long-Lasting Survival
Lin J, Yang X, Xie Y, Zhao H
OncoTargets and Therapy 2019, 12:9941-9945
Published Date: 19 November 2019
Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma
Huang H, Wan X, Bai Y, Bian J, Xiong J, Xu Y, Sang X, Zhao H
Cancer Management and Research 2019, 11:5157-5162
Published Date: 4 June 2019
Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis
Xiong JP, Xu WY, Bian J, Huang HC, Bai Y, Xu YY, Lu X, Zhao HT
Cancer Management and Research 2018, 10:4095-4104
Published Date: 1 October 2018
Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case–control study in China
Xiong J, Lu X, Xu W, Bai Y, Huang H, Bian J, Zhang L, Long J, Xu Y, Wang Z, Zhao H
Cancer Management and Research 2018, 10:3849-3855
Published Date: 24 September 2018